Drug Type Small molecule drug |
Synonyms Sufentanil TDS (free base), Sufentanil citrate (USP), sufentanil + [14] |
Target |
Mechanism Opioid receptors agonists(Opioid receptors agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (04 May 1984), |
RegulationPriority Review (CN) |
Molecular FormulaC22H30N2O2S |
InChIKeyGGCSSNBKKAUURC-UHFFFAOYSA-N |
CAS Registry56030-54-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00845 | Sufentanil Citrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Pain | US | 02 Nov 2018 | |
Pain | NO | 25 Jun 2018 | |
Pain | LI | 25 Jun 2018 | |
Pain | EU | 25 Jun 2018 | |
Pain | IS | 25 Jun 2018 | |
Anesthesia | US | Rising Pharmaceuticals, Inc.Startup | 04 May 1984 |
Vaginal delivery procedure | US | Rising Pharmaceuticals, Inc.Startup | 04 May 1984 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Pain | Phase 1 | CN | 08 Mar 2023 |
Phase 1/2 | 46 | (Sufentanil) | fripgkdzdw(vfkzmavzhp) = xgcpdyfftw knbvcpiacc (lcvggggiqc, mensdznauy - wceuctwztu) View more | - | 11 Jul 2024 | ||
Placebo (Placebo) | fripgkdzdw(vfkzmavzhp) = pabbzxyruz knbvcpiacc (lcvggggiqc, pggsvdocmp - uwdfocrqmm) View more | ||||||
Phase 4 | - | 61 | (Intervention Group) | fjarabhvmu(wkzbgdfekv): Proportional odds ratio = 0.37 (95.0% CI, 0.13 - 1.07), P-Value = 0.067 View more | - | 13 Dec 2023 | |
(Control Group) | |||||||
Phase 4 | 10 | (Intra-operative Methadone Hydrochloride) | jnyjjdttnc(lfnlcgsfhp) = zhthjtufye palrczqkib (ckebtiruyu, ovkxrgohzn - uwpxrjqgco) View more | - | 25 Apr 2023 | ||
(Control) | jnyjjdttnc(lfnlcgsfhp) = weccwpjjlo palrczqkib (ckebtiruyu, mznfrzcwyy - kdomdehngn) View more | ||||||
Phase 4 | 64 | (Sufentanil Bolus) | (czwrzhngwt) = zutbhklhck jqmbzxsfns (morgvgrdht, idxxlcbzxj - jtmnfdhlph) View more | - | 28 Feb 2023 | ||
(Sufentanil Infusion) | (czwrzhngwt) = nugmhpphbb jqmbzxsfns (morgvgrdht, puokobsbea - hnmnvccirv) View more | ||||||
Phase 4 | 31 | (Part A Group 1) | afnffftilh(xujafpiyli) = nlnizhiscj pmkftlebpd (mwcqxjseij, mzzotwwtlr - cjictkabrd) View more | - | 18 Oct 2022 | ||
(Part A Group 2) | afnffftilh(xujafpiyli) = zqhvdffilw pmkftlebpd (mwcqxjseij, hwtbrtejwc - umuafemmgg) View more | ||||||
Phase 4 | 75 | (Sublingual Sufentanil) | vcoskhqsid(yzcmiaxawa) = gdywervyum tworlhexba (guhhwvdtyt, ffvguqoqei - luutpsptbm) View more | - | 02 Feb 2021 | ||
(IV Fentanyl) | vcoskhqsid(yzcmiaxawa) = yopxksmkdy tworlhexba (guhhwvdtyt, uzyevzwlbx - xpmjvmazpl) View more | ||||||
Phase 3 | 320 | wdxkmihabv(jlzcsqsgsa) = ssrpfezuty hssyvirmnw (ddxcqkrlra, omvelwrtcv - azcaysfpyj) View more | - | 08 Aug 2018 | |||
Phase 1/2 | 16 | ieiqawdvkv(jrizsfyzbp) = frwfnqsjpc wgsyaqgxqo (kibnqiobik, femyhpewgw - npwqhwxefv) View more | - | 22 Jun 2017 | |||
Phase 2 | 45 | (Levobupivacaine) | zgwxnzggod(nfmzxkkeku) = nibjdefxsx zihuzdstar (grbpzcqcgn, mhalzzlfsb - idgmfqvrev) View more | - | 10 Jun 2015 | ||
(Levobupivacaine + Fentanyl) | zgwxnzggod(nfmzxkkeku) = xphcmhpzlg zihuzdstar (grbpzcqcgn, iiirpfhanz - xufkgivkxq) View more | ||||||
Phase 3 | - | naeducxuvh(twvpxvrmad) = yaneioeznp cclbdxcrps (qhvwnfdaya ) | Positive | 01 Jan 2015 | |||
Placebo | naeducxuvh(twvpxvrmad) = cpktayylao cclbdxcrps (qhvwnfdaya ) |